Drug intelligence / Profile preview

flavonoid d

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Flavonoid d refers to one of a group of flavonoids extracted from the whole herb of Lomatogonium rotatum, a plant used in Mongolian Chinese Materia Medica. These flavonoids have demonstrated hypolipidemic and obesity-inhibiting effects in preclinical studies. In male Wistar rats fed a high-fructose diet, administration of these flavonoids for 12 weeks led to decreased serum levels of fasting blood glucose, feeding blood glucose, and leptin, as well as reduced triglyceride and cholesterol levels, and increased high-density lipoprotein-cholesterol (HDL-C). The mechanism of action involves the downregulation of leptin levels, reduction of fatty acid synthase (FAS) protein expression, and enhancement of threonine-172 phosphorylation of adenosine monophosphate-activated protein kinase (AMPK) in the liver. These actions suggest that flavonoid d, and similar flavonoids, may inhibit FAS activity and stimulate AMPK, similar to epigallocatechin gallate.

02

Targets

5'-AMP-activated protein kinase subunit gamma CBS domains

Beyond the preview

Go deeper on flavonoid d.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on flavonoid d.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call